Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay

Fig. 1

Comparison of the mean survival ± standard deviation after DHA treatment, obtained from the [3H]hypoxanthine incorporation method and the conventional microscopic readout with the Plasmodium falciparum clinical isolate Cam3.IR539T. In all assays, Cam3.IR539T was exposed for 6 h to 700 nM of DHA. For both readouts, the mean values of n = 4 biological replicates are shown

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us